Chief, Senior Investigator
National Institute on Aging
Dr. Arya Biragyn received his Ph.D. from the Institute of Molecular Biology at Engelgardt, Academy of Sciences of Russia, Moscow, in 1991, and postdoctoral training from the University of Illinois at Urbana and the National Cancer Institute (1991-1996). From 1996-2000 he was a scientist at SAIC, Frederick, MD, where he worked on the development of new generation therapeutic vaccines for B cell lymphomas. In 2000 he moved to the Vaccine Biology Section, National Cancer Institute as a Staff Scientist, where he continued his cancer vaccine studies. From 2003 to 2011, he was a tenure-track investigator at the Laboratory of Immunology. Since 2011, he is a tenured Senior investigator, Chief of Immunoregulation section, Laboratory of Molecular Biology and Immunology, National Institute on Aging, Baltimore.
His research focus is to understand the “immunological paradox of aging”; that is, why cancer incidence is enhanced but cancers often grow more slowly in older people, and why autoimmunity is more prevalent in the elderly but older people have poor vaccine responses. He studies immune dysregulation in cancer and aging to gain insight on the role of regulatory immune cells and to develop potent immunotherapeutics tailored for elderly.
Bodogai M, et al. Science Transl. Med., 2018.
Biragyn A and Ferrucci. Lancet Oncol., 2018.
Lee-Chang C, et al. Blood. 2014..
Bodogai M, et al. Cancer Res. 2015.
Olkhanud PB, et al., Cancer Res. 2011.
Biragyn A, et al. Science. 2002.
Thursday, June 20
1:00 PM – 1:25 PM